83 related articles for article (PubMed ID: 21728427)
1. Is the apolipoprotein e genotype a biomarker for mild cognitive impairment? Findings from a nationally representative study.
Brainerd CJ; Reyna VF; Petersen RC; Smith GE; Taub ES
Neuropsychology; 2011 Nov; 25(6):679-89. PubMed ID: 21728427
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E alleles in Cuban patients with mild cognitive impairment.
Suárez VM; Fernández Y; López Edel C; Clarke DH; Bobes MA; Riverón AM; López-Cánovas L
Am J Alzheimers Dis Other Demen; 2014 May; 29(3):236-41. PubMed ID: 24370622
[TBL] [Abstract][Full Text] [Related]
3. Frequency of the apolipoprotein E ε4 allele in a memory clinic cohort in Beijing: a naturalistic descriptive study.
Wang X; Wang H; Li H; Li T; Yu X
PLoS One; 2014; 9(6):e99130. PubMed ID: 24914687
[TBL] [Abstract][Full Text] [Related]
4. Motor timing intraindividual variability in amnestic mild cognitive impairment and cognitively intact elders at genetic risk for Alzheimer's disease.
Kay CD; Seidenberg M; Durgerian S; Nielson KA; Smith JC; Woodard JL; Rao SM
J Clin Exp Neuropsychol; 2017 Nov; 39(9):866-875. PubMed ID: 28052734
[TBL] [Abstract][Full Text] [Related]
5. APOE ε4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease.
Moore AM; Mahoney E; Dumitrescu L; De Jager PL; Koran MEI; Petyuk VA; Robinson RA; Ruderfer DM; Cox NJ; Schneider JA; Bennett DA; Jefferson AL; Hohman TJ
Neurobiol Aging; 2020 Mar; 87():18-25. PubMed ID: 31791659
[TBL] [Abstract][Full Text] [Related]
6. Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P.
Borenstein AR; Mortimer JA; Ding Ding ; Schellenberg GD; DeCarli C; Qianhua Zhao ; Copenhaver C; Qihao Guo ; Shugang Chu ; Galasko D; Salmon DP; Qi Dai ; Yougui Wu ; Petersen R; Zhen Hong
Am J Alzheimers Dis Other Demen; 2010 May; 25(3):233-8. PubMed ID: 20142627
[TBL] [Abstract][Full Text] [Related]
7. Five-Year Change in Body Mass Index Predicts Conversion to Mild Cognitive Impairment or Dementia Only in APOE ɛ4 Allele Carriers.
Kadey KR; Woodard JL; Moll AC; Nielson KA; Smith JC; Durgerian S; Rao SM
J Alzheimers Dis; 2021; 81(1):189-199. PubMed ID: 33749649
[TBL] [Abstract][Full Text] [Related]
8. APOE ε4 positivity predicts centrality of episodic memory nodes in patients with mild cognitive impairment: A cohort-based, graph theory-informed study of cognitive networks.
De Marco M; Wright LM; Valera Bermejo JM; Ferguson CE
Neuropsychologia; 2024 Jan; 192():108741. PubMed ID: 38040087
[TBL] [Abstract][Full Text] [Related]
9. Timing of Physical Activity, Apolipoprotein E ε4 Genotype, and Risk of Incident Mild Cognitive Impairment.
Krell-Roesch J; Pink A; Roberts RO; Stokin GB; Mielke MM; Spangehl KA; Bartley MM; Knopman DS; Christianson TJ; Petersen RC; Geda YE
J Am Geriatr Soc; 2016 Dec; 64(12):2479-2486. PubMed ID: 27801933
[TBL] [Abstract][Full Text] [Related]
10. Late-Life Body Mass Index, Rapid Weight Loss, Apolipoprotein E ε4 and the Risk of Cognitive Decline and Incident Dementia.
Bell SP; Liu D; Samuels LR; Shah AS; Gifford KA; Hohman TJ; Jefferson AL
J Nutr Health Aging; 2017; 21(10):1259-1267. PubMed ID: 29188888
[TBL] [Abstract][Full Text] [Related]
11. APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts.
Qian J; Wolters FJ; Beiser A; Haan M; Ikram MA; Karlawish J; Langbaum JB; Neuhaus JM; Reiman EM; Roberts JS; Seshadri S; Tariot PN; Woods BM; Betensky RA; Blacker D
PLoS Med; 2017 Mar; 14(3):e1002254. PubMed ID: 28323826
[TBL] [Abstract][Full Text] [Related]
12. Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic.
Valero S; Marquié M; De Rojas I; Espinosa A; Moreno-Grau S; Orellana A; Montrreal L; Hernández I; Mauleón A; Rosende-Roca M; Alegret M; Pérez-Cordón A; Ortega G; Roberto N; Sanabria A; Abdelnour C; Gil S; Tartari JP; Vargas L; Esteban-De Antonio E; Benaque A; Tárraga L; Boada M; Ruíz A
Sci Rep; 2020 Nov; 10(1):20058. PubMed ID: 33208795
[TBL] [Abstract][Full Text] [Related]
13. Critical Values of Daily Sedentary Time and Its Longitudinal Association with Mild Cognitive Impairment Considering APOE ε4: A Prospective Cohort Study.
Duan H; He X; Yang T; Xu N; Wang Z; Li Z; Chen Y; Du Y; Zhang M; Yan J; Sun C; Wang G; Ma F; Li W; Li X; Huang G
J Prev Alzheimers Dis; 2024; 11(3):582-588. PubMed ID: 38706274
[TBL] [Abstract][Full Text] [Related]
14. Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications.
Burke SL; Hu T; Spadola CE; Li T; Naseh M; Burgess A; Cadet T
Sleep Med; 2018 Dec; 52():168-176. PubMed ID: 30359892
[TBL] [Abstract][Full Text] [Related]
15. Cerebellar EEG source localization reveals age-related compensatory activity moderated by genetic risk for Alzheimer's disease.
Paitel ER; Nielson KA
Psychophysiology; 2023 Dec; 60(12):e14395. PubMed ID: 37493042
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.
Beydoun MA; Boueiz A; Abougergi MS; Kitner-Triolo MH; Beydoun HA; Resnick SM; O'Brien R; Zonderman AB
Neurobiol Aging; 2012 Apr; 33(4):720-731.e4. PubMed ID: 20619505
[TBL] [Abstract][Full Text] [Related]
17. Associations of serum DNA methylation levels of chemokine signaling pathway genes with mild cognitive impairment (MCI) and Alzheimer's disease (AD).
Zou T; Zhou X; Wang Q; Zhao Y; Zhu M; Zhang L; Chen W; Abuliz P; Miao H; Kabinur K; Alimu K
PLoS One; 2023; 18(12):e0295320. PubMed ID: 38039290
[TBL] [Abstract][Full Text] [Related]
18. Midlife alcohol consumption and later life cognitive impairment: Light drinking is not protective and APOE genotype does not change this relationship.
Chosy EJ; Edland S; Launer L; White LR
PLoS One; 2022; 17(3):e0264575. PubMed ID: 35275952
[TBL] [Abstract][Full Text] [Related]
19. The Health and Retirement Study Harmonized Cognitive Assessment Protocol Project: Study Design and Methods.
Langa KM; Ryan LH; McCammon RJ; Jones RN; Manly JJ; Levine DA; Sonnega A; Farron M; Weir DR
Neuroepidemiology; 2020; 54(1):64-74. PubMed ID: 31563909
[TBL] [Abstract][Full Text] [Related]
20. Testing for Interactions Between APOE and Klotho Genotypes on Cognitive, Dementia, and Brain Imaging Metrics in UK Biobank.
Tank R; Ward J; Celis-Morales C; Smith DJ; Flegal KE; Lyall DM
J Alzheimers Dis; 2021; 83(1):51-55. PubMed ID: 34219715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
